Nobilis Influenza H5N2

Authorised

This medicine is authorised for use in the European Union

adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

Nobilis Influenza H5N2 : Summary for the public

Product information

Nobilis Influenza H5N2 : EPAR - Product Information

Nobilis Influenza H5N2 : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Nobilis Influenza H5N2
• Active substance:
  inactivated whole avian influenza virus antigen of H5N2 subtype (strain A/duck/Potsdam/1402/86)
• International non-proprietary name (INN) or common name:
  adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5

Authorisation details

• EMA product number:
  EMEA/V/C/000118
• Accelerated assessment:

  This medicine had an accelerated assessment. This means that it is a medicine of major interest for public health, so its timeframe for review was 150 evaluation days rather than 210. For more information, see Accelerated assessment.

Assessment history

Changes since initial authorisation of medicine

Nobilis Influenza H5N2 : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Nobilis Influenza H5N2 : EPAR - Scientific Discussion